AssureRx
March 7, 2012 source: Angel Capital Association (ACA) AssureRx Health, Inc. Receives 2012 ACA Luis Villalobos Award for Innovation Angel Capital Association Recognizes Company For Industry-leading Personalized Medicine Solution Hats off to one of my portfolio companies, AssureRx today received the the 2012 Luis Villalobos Award from the Angel Capital Association (ACA), the trade association of […]
Read More
January 18, 2012 source: MedCity News Personalized medicine company AssureRx Health has released the next-generation version of its genetic screening test for psychiatric drugs. The Cincinnati-area company’s GeneSightRx test, which helps doctors pick the right psychiatric drugs for patients based on their genes, was launched in 2009. The test uses a cheek swab, mathematical […]
Read More
It is always great to brag and cheer about one of our portfolio companies. Working with portfolio companies to help them succeed is one of a VC’s key jobs, and helping build an executive team is an area where a VC can help a lot. We are pleased to announce that AssureRx Health has just […]
Read MoreMay 11, 2011 source: Wall Street Journal Health Blog Public Education and Gene Testing to Improve Medication Adherence There are tons of reasons why people don’t take the medications they’ve been prescribed, including side effects, cost and complicated drug regimens. A couple of different approaches to improving adherence are in the news today. The first […]
Read MoreMarch 25, 2011 source: VentureWire by Timothy Hay AssureRx Health Inc. has raised an $11 million Series B round from Sequoia Capital and Claremont Creek Ventures for its testing system that helps psychiatric patients find the most compatible medications, according to an investor. “This could be one of the biggest diagnostic companies of the decade, […]
Read More
– Personalized Medicine Company to Expand Marketing and Product Development for Neuropsychiatric Pharmacogenetics – CINCINNATI, March 25, 2011 – AssureRx Health, Inc. today announced the closing of an $11 million Series B financing. The personalized medicine company, which provides clinically-relevant information to help physicians select the right drug and the right dose for individual neuropsychiatric […]
Read MoreMeet our team
Claremont Creek Ventures was founded in 2005 by Nat Goldhaber, John Steuart and Randy Hawks to pursue early stage investing in exceptional technology startups.
NAT GOLDHABER
Nat Goldhaber is a co-founder of Claremont Creek Ventures.
BRAD WEBB
Brad is focused on the role of genomics and biomarker data analytics in driving the next generation of diagnostics and drug development.
RANDY HAWKS
Randy Hawks is a co-founder of Claremont Creek Ventures.